Barclays’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-10,400
| Closed | -$209K | – | 4845 |
|
|
2020
Q4 | $209K | Hold |
10,400
| – | – | ﹤0.01% | 3742 |
|
|
2020
Q3 | $254K | Hold |
10,400
| – | – | ﹤0.01% | 3688 |
|
|
2020
Q2 | $247K | Sell |
10,400
-8,400
| -45% | -$195K | ﹤0.01% | 3900 |
|
|
2020
Q1 | $324K | Sell |
18,800
-7,100
| -27% | -$130K | ﹤0.01% | 3931 |
|
|
2019
Q4 | $456K | Sell |
25,900
-96,900
| -79% | -$1.64M | ﹤0.01% | 4380 |
|
|
2019
Q3 | $2.17M | Sell |
122,800
-1,600
| -1% | -$32.4K | ﹤0.01% | 2761 |
|
|
2019
Q2 | $2.66M | Buy |
124,400
+75,400
| +154% | +$1.58M | ﹤0.01% | 2578 |
|
|
2019
Q1 | $1.17M | Sell |
49,000
-99,700
| -67% | -$2.27M | ﹤0.01% | 3235 |
|
|
2018
Q4 | $2.92M | Buy |
148,700
+45,800
| +45% | +$817K | ﹤0.01% | 2028 |
|
|
2018
Q3 | $1.82M | Sell |
102,900
-52,100
| -34% | -$1.02M | ﹤0.01% | 2992 |
|
|
2018
Q2 | $3.34M | Buy |
155,000
+34,300
| +28% | +$709K | ﹤0.01% | 2079 |
|
|
2018
Q1 | $2.67M | Buy |
120,700
+44,800
| +59% | +$1.24M | ﹤0.01% | 2189 |
|
|
2017
Q4 | $2.31M | Sell |
75,900
-28,000
| -27% | -$745K | ﹤0.01% | 2300 |
|
|
2017
Q3 | $2.52M | Buy |
103,900
+62,400
| +150% | +$1.66M | ﹤0.01% | 2122 |
|
|
2017
Q2 | $1.02M | Buy |
41,500
+6,800
| +20% | +$144K | ﹤0.01% | 2866 |
|
|
2017
Q1 | $752K | Sell |
34,700
-77,600
| -69% | -$1.58M | ﹤0.01% | 2999 |
|
|
2016
Q4 | $1.67M | Buy |
112,300
+1,300
| +1% | +$18.8K | ﹤0.01% | 2273 |
|
|
2016
Q3 | $1.42M | Sell |
111,000
-2,600
| -2% | -$28.1K | ﹤0.01% | 2292 |
|
|
2016
Q2 | $887K | Buy |
113,600
+95,500
| +528% | +$550K | ﹤0.01% | 2720 |
|
|
2016
Q1 | $72K | Buy |
18,100
+6,900
| +62% | +$29.2K | ﹤0.01% | 4562 |
|
|
2015
Q4 | $56K | Sell |
11,200
-16,500
| -60% | -$92.3K | ﹤0.01% | 4723 |
|
|
2015
Q3 | $139K | Sell |
27,700
-105,400
| -79% | -$573K | ﹤0.01% | 4394 |
|
|
2015
Q2 | $399K | Buy |
133,100
+129,800
| +3,933% | +$422K | ﹤0.01% | 3652 |
|
|
2015
Q1 | $7K | Sell |
3,300
-110,600
| -97% | -$257K | ﹤0.01% | 6415 |
|
|
2014
Q4 | $114K | Sell |
113,900
-1,700
| -1% | -$2.65K | ﹤0.01% | 5088 |
|
|
2014
Q3 | $115K | Buy |
115,600
+32,400
| +39% | +$104K | ﹤0.01% | 5215 |
|
|
2014
Q2 | $250K | Sell |
83,200
-60,700
| -42% | -$210K | ﹤0.01% | 4613 |
|
|
2014
Q1 | $432K | Buy |
143,900
+127,500
| +777% | +$868K | ﹤0.01% | 4082 |
|
|
2013
Q4 | $98K | Sell |
16,400
-1,100
| -6% | -$6.06K | ﹤0.01% | 5653 |
|
|
2013
Q3 | $88K | Buy |
17,500
+7,700
| +79% | +$39.9K | ﹤0.01% | 5708 |
|
|
2013
Q2 | $44K | Buy |
+9,800
| New | +$46.4K | ﹤0.01% | 6382 |
|
Other funds holding EXEL
FCM
VPM
VCM
Barclays's EXEL Position: Q1 2026 in Review
Barclays reduced its Exelixis (EXEL) stake by 37% in Q1 2026, selling an estimated $12.9M and leaving 504,289 shares worth $21.6M. The position accounts for 0.01% of the portfolio, ranked #1063.
Barclays first reported a position in EXEL in Q2 2013 and has held it in 52 quarters since. The position peaked at $35.3M in Q4 2025. 695 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.
- Barclays held 504,289 shares of Exelixis worth $21.6M as of Q1 2026.
- Barclays sold 300,762 Exelixis shares in Q1 2026, an estimated $12.9M.
- Exelixis made up 0.01% of Barclays's portfolio in Q1 2026, its #1063 holding.
- Barclays first reported a position in Exelixis in Q2 2013 and has held it in 52 quarters since.
- Barclays's Exelixis position peaked at $35.3M in Q4 2025.
- 695 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.